Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3857)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2024 (publication date) through Jan 4, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Liu Chen Kiow J, Hoang T, Bedi HK, Majdzadeh Ardekani Z, Rosenfeld D, Reise-Filteau M, Bressler B, Leung Y, Rosenfeld G. Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease. World J Gastroenterol 2024; 30(46): 4904-4913 [PMID: 39679312 DOI: 10.3748/wjg.v30.i46.4904] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Liu Chen Kiow J, Hoang T, Bedi HK, Majdzadeh Ardekani Z, Rosenfeld D, Reise-Filteau M, Bressler B, Leung Y, Rosenfeld G. Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease. World J Gastroenterol 2024; 30(46): 4904-4913 [PMID: 39679312 DOI: 10.3748/wjg.v30.i46.4904] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i46/4904.htm |
| Number | Citing Articles |
| 1 |
Mahmoud H. Mosli, Badr Al-Bawardy, Turki AlAmeel, Nahla A. Azzam, Shakir A. Bakkari, Othman R. Alharbi, Abdulelah Almutairdi, Yaser K. Meeralam, Omar I. Saadah, Majid A. Almadi, Waleed Alhazzani, Haifa F. Alotaibi, Khalidah A. Alenzi, Bedor A. Al-Omari, Hajer Y. Almudaiheem, Ahmed H. Al-Jedai. Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease. Saudi Journal of Gastroenterology 2025; doi: 10.4103/sjg.sjg_277_25
|
| 2 |
Justin Kritzinger, Ivanna Candel, Gynter Kotrri, Huzaifa Nadeem, Waqqas Afif, Alain Bitton, Gary Wild, Talat Bessissow, Peter Laszlo Lakatos. Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(48): 114355 doi: 10.3748/wjg.v31.i48.114355
|